Beneficial effect of rituximab monotherapy in multifocal motor neuropathy
Authors:
- Raffi TopakianRTRaffi Topakian
- 1 July 2009
- journal article
- case report
- Published by Elsevier in Neuromuscular Disorders
- Vol. 19 (7) , 473-475
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Advances in the understanding of the mechanism of action of IVIgJournal of Neurology, 2008
- Invited Article: Inhibition of B cell functionsNeurology, 2008
- Rituximab treatment in patients with IVIg‐dependent immune polyneuropathy: A prospective pilot trialMuscle & Nerve, 2006
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy*European Journal of Neurology, 2006
- High-dose rituximab and anti-MAG–associated polyneuropathyNeurology, 2006
- Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIgNeurology, 2004
- Chronic neuropathy with IgM anti-ganglioside antibodies: Lack of long term response to rituximabNeurology, 2003
- Treatment of IgM antibody associated polyneuropathies using rituximabJournal of Neurology, Neurosurgery & Psychiatry, 2003
- IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using RituximabNeurology, 1999
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991